Document:

Exhibit 10.13

 

ROBERT
POTASHNICK EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (the “Agreement”)
is made and entered into on this

29th day of December 2020, by and between
FOXO Technologies, Inc., a Delaware corporation (the Company”) and Robert Potashnick (the “Executive”).

 

RECITALS

 

WHEREAS, the
Company desires to enter into this Agreement with the Executive for his full-time employment to serve as its Chief Financial Officer;
and

 

WHEREAS, the
Executive desires to serve as the Chief Financial Officer of the Company and enter into this Agreement with the Company.

 

NOW, THEREFORE,
in consideration of the recitals above and the mutual covenants and promises contained herein, and other good and valuable consideration,
the receipt and sufficiency of which are hereby expressly acknowledged, the Company and Executive (collectively the “Parties”
and each a “Party”) agree as follows:

 

		1.	Title, Duties and Term of Employment:

 

(a) Executive
will serve as the Chief Financial Officer of the Company and report to the Company’s Chief Executive Officer and Board of Directors.
Executive understands and agrees that the Company is a rapidly growing organization and the precise nature of the work of the Chief Financial
Officer asked to be completed on behalf of the Company may be adjusted from time to time but, in any event, the duties and responsibilities
will include those duties and responsibilities normally associated with and appropriate for someone in the position of Chief Financial
Officer, which shall include, but not be limited to preparing and maintaining the Company’s financial reporting to the SEC in compliance
with GAAP and all regulatory requirements, providing day-to- day effective oversight of all operational and regulatory matters, ensuring
operational integrity and best practices; helping the Company to achieve and exceed strategic and operating goals; presenting and maintaining
investor relationships in support of the strategies and objectives of the Company; advising the Board of Directors (“Board”)
and the Chief Executive Officer concerning Company performance, strategy, operations, initiatives and developments in the industry; working
with outside accounting, audit, tax, SOX, legal counsel, advisors, and other vendors appropriate; and travel as needed and requested by
the Company.

 

(b) Executive
shall perform his duties and responsibilities to the best of his professional skill and ability. In all such matters, Executive will act
in good faith, in the best interests of the Company.

 

(c) Executive’s
employment under this Agreement shall commence on or before January 14, 2021 (the “Commencement Date”). Executive’s
employment shall continue until such time either party terminates this agreement pursuant to paragraph 3 of this Agreement. The period
during which Executive’s employment continues in effect pursuant to this Agreement is hereinafter referred to as the Employment
Period.

 

     

     

    

 

		2.	Compensation: During the Employment Period, Executive shall be compensated as follows:

 

(a) Base
Salary: As used in this Agreement, the term “Base Salary” refers to the annual amount of Executive’s salary, and does
not include any other amounts. For example, Base Salary does not include option or incentive compensation or bonus awards. For the services
to be rendered by Executive, the Company agrees to pay Executive a Base Salary of $180,000 per year, subject to all payroll deductions
as required by law. Executive’s Base Salary shall be reviewed annually throughout the Employment Period.

 

(b) Standard
Incentive Compensation: The Executive shall participate in the Company’s discretionary Standard Incentive Compensation Plan. The
Standard Incentive Compensation Plan is subject to review and change by the approval of the Board of Directors. Currently, the Company’s
Standard Incentive Compensation Plan provides all employees with the opportunity to receive an annual bonus of up to 20% of an individual’s
base salary, paid semi- annually pursuant to management performance reviews. The Company may pay the Standard Incentive Compensation bonus
compensation in the form of cash or stock options.

 

(c) Executive
Incentive Compensation: The Compensation Committee of the Board of Directors shall work with the Executive to develop an Executive Incentive
Compensation plan that creates benchmark goals and objectives for key executives and provides additional bonus compensation opportunities
key executives to receive additional annual bonus of up to 20% of an individual’s Base Salary upon achievement of specified goals
and objectives of the Company. In the absence of the development of such Executive Incentive Compensation plan, the Executive shall be
eligible for an additional annual bonus of up to 20% of the Executive’s Base Salary based on meeting the objectives in the Standard
Incentive Compensation Plan.

 

(d) Signing
Bonus & Initial Option Grant: Within thirty days of the Commencement Date, the Company shall compensate the Executive with (i) a cash
compensation signing bonus of

$30,000; and (ii) an initial grant
of incentive stock options valued in an amount of $360,000 of the Company’s common stock, with a strike price of approximately $3.60
per share (subject to final adjustment per the Company’s Certificate of Incorporation) and shall vest in accordance with the Company’s
2020 Equity Incentive Compensation Plan and Incentive Stock Option Agreement (copies of which have been provided to the Executive).

 

(e) Benefit
Plans and Programs: Beginning on the Commencement Date, Executive shall be entitled to participate in all employee benefit plans and programs
made available by the Company to the Company’s executive employees generally, including, without limitation: health insurance, dental
insurance, life insurance, disability insurance, 401k plan and health spending account (HSA) plan. During the Employment Period, the Company
shall the same portion of the costs of such benefits and programs as other senior executive employees for Executive. In the event that
the provision of, or payment for, such benefits is prohibited or otherwise adversely impacted by the Patient Protection and Affordable
Care Act or other similar laws, the Parties shall negotiate in good faith to determine an equitable benefit in lieu thereof.

 

(f) Vacation
and Personal Days: Executive shall receive paid vacation during the Employment Period of no less than 20 days per calendar year.

 

(g) Reimbursement: Executive
is authorized to incur reasonable expenses in carrying out the Executive’s duties for the Company under this Agreement and shall
be entitled to reimbursement for all reasonable business expenses, including but not limited to Executive’s monthly cell phone
bill, that Executive incurs during the Employment Period. The Company also agrees to reimburse Executive for all reasonable expenses incurred
in relation to keeping Executive’s CPA license active, including but not limited to annual dues for the AICPA, MNCPA, and Minnesota
Board of Accountancy, and fees for continuing professional education courses.

 

    

    Page2

    

 

		3.	Termination of Employment:

 

(a) Terms
Applicable to Any Type of Termination: In the event of a termination of Executive’s employment, the Company shall pay Executive:
(A) any unpaid Base Salary on the Company’s regular payday, prorated to the effective date of termination; and (B) the dollar value
of all accrued and unused vacation benefits based upon Executive’s Base Salary. The Company shall also reimburse Executive in accordance
with and subject to the requirements of the Company’s expense reimbursement practices for any reasonable and necessary business
expenses incurred by Executive on behalf of the Company on or before the date on which his employment terminates, and reported and properly
documented on expense reports.

 

(b) Termination
Without Cause: The Company shall have the right to terminate Executive’s employment without cause during the Employment Period upon
notice to Executive. In the event of a Termination Without Cause, the Company will pay Executive severance compensation in an amount equal
to an amount of one half of Executive’s Base Salary in effect on the date on which Executive’s employment is terminated, payable
in a lump sum within thirty (30) days after the date of the termination. If Executive is eligible for and elects to continue group health
coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”). The Company will also pay Executive a
bonus under the Incentive Compensation Plan prorated based upon the number of days for which Executive was employed during the period
for which such payments are made (e.g., quarter), and any Options or other equity incentives which have been granted to Executive shall
fully vest on the date of termination.

 

(c) Termination
For Cause: The Company shall have the right immediately to terminate Executive’s employment for cause during the Employment Period
upon notice to Executive.

 

(i) Termination
For Cause shall mean:

 

(A) A
breach by Executive of any term of this Agreement or of Executive’s fiduciary duties to the Company, which breach remains uncured
more than thirty (30) days after Executive receives written notice from Company specifying such breach;

 

(B) The
material failure of Executive to perform Executive’s duties or responsibilities as Chief Financial Officer which remains uncured
more than thirty (30) days after Executive receives written notice from Company specifying such failure (“Failure Notice”);

 

(C) Executive’s
violation of any law, statute or regulation relating to the operation of the Company’s business; or

 

(D) The
commission of, or conviction for (or its procedural equivalent), or the entering of a guilty plea or plea of no contest with respect to,
a crime or any conduct of Executive which involves moral turpitude.

 

(ii) If
Executive’s employment is Terminated For Cause, except as set forth in subparagraph 3(a), the Company shall have no obligation to
make payments of any kind to Executive.

 

    

    Page3

    

 

(d) Resignation
for Good Reason: Executive shall have the right to resign from employment with the Company for Good Reason during the Employment Period
upon notice to the Company.

 

(i) As
used in this Agreement, the term “Good Reason” means (a) a breach of this Agreement by the Company which breach, where curable,
has not been cured within thirty (30) days after written notice to the Company setting forth the particulars of such alleged breach; (b)
a reduction in Executive’s Base Salary; (c) assignment to Executive of duties inconsistent with the Executive’s position,
or a diminution in Executive’s authority, responsibility, status, title, or offices; (d) relocation of Executive’s primary
office to a location more than thirty (30) miles away from Executive’s primary office location as of the Commencement Date; (f)
a Change in Control; and (j) the failure of the Company to comply fully with its obligations under subparagraph 9(d) of this Agreement.
The Executive shall not be able to resign for Good Reason once the Executive has been provided a Failure Notice under Section 3(c)(i)(B)
until such time the Company has agreed in writing that such failure has been cured (a “Remedied Notice”).

 

(ii) In
the event of a Resignation for Good Reason, Executive shall be entitled to all payments and other benefits provided under subparagraphs
3(a) and 3(b) above.

 

(e) Voluntary
Resignation: Executive may voluntarily resign Executive’s employment under this Agreement without Good Reason at any time; however
Executive agrees to provide at least thirty (30) days advance written notice to the Company.

 

(f) Death:
If Executive’s employment ends through Executive’s death, Executive shall be entitled to all payments and other benefits provided
under subparagraph 3(a) above. The Company will also pay Executive’s estate a bonus under the any incentive compensation plans prorated
based upon the number of days for which Executive was employed during the period for which such payments are made (e.g., quarter).

 

		4.	Confidential Information:

 

(a) Confidential
Information: As used in this Agreement, the term “Confidential Information” means information in whatever form, pertaining
to the business of the Company that is not generally known outside of the Company, or that is known outside of the Company through improper
means. Without limiting the foregoing definition, Confidential Information includes, but is not limited to: (i) technical information,
formulas, teaching and development techniques, methodologies, processes, trade secrets, computer programs, electronic codes, designs,
product development information, inventions, improvements, and research projects; (ii) information about finances, costs, profits, markets,
proposals, sales, and lists of customers or clients; (iii) business, marketing, and strategic plans; and (iv) employee personnel files
and compensation information.

 

(b) Non-Disclosure of Confidential
Information: During the Employment Period, Executive agrees to hold all Confidential Information in strict confidence and trust for the
sole benefit of the Company and Executive agrees that Executive will not disclose any Confidential Information, directly or indirectly,
to anyone outside of the Company, and Executive will not use, copy, publish, summarize, or remove from Company premises Confidential
Information except to the extent necessary to carry out Executive’s responsibilities as an employee of the Company. After Executive’s
employment with the Company ends, Executive will not, directly or indirectly, use or disclose any Confidential Information to any person
or entity, except as authorized in advance by an officer of the Company in writing. The restrictions in this subparagraph, however, will
not apply to Confidential Information that is or has become known to the public generally through no fault of or breach by Executive,
or was previously known to Executive other than as a result of employment with the Company.

 

    

    Page4

    

 

		5.	Non-Solicitation Covenants:

 

(a) Non-Solicitation
of Employees: Executive agrees that, during the Employment Period, and for a period of twelve (12) months following the termination of
Executive’s employment, regardless of the reason for such termination, Executive will not, directly or indirectly, solicit, or attempt
to solicit, for employment, with Executive or with any other person or entity, any employee of the Company.

 

(b) Non-Solicitation
of Customers or Financing Relationships: Executive agrees that, during the Employment Period, and for a period of twelve (12) months following
the termination of Executive’s employment, regardless of the reason for such termination, Executive will not, directly or indirectly,
solicit any business for Executive, or for any other person or entity, from any client or financing relationship of the Company with which
Executive had contact within the twelve

(12) months prior to the termination
of Executive’s employment with the Company or concerning which Executive had access to Confidential Information, during and by virtue
of Executive’s employment with the Company.

 

		6.	Resolution of Disputes:

 

The Parties
agree submit any disputes between them to final and binding arbitration pursuant to the then-current AAA national rules for the resolution
of employment disputes before a neutral arbitrator selected from the list of Arbitrators. THE PARTIES EXPRESSLY AGREE THAT SUCH ARBITRATION
SHALL BE THE EXCLUSIVE REMEDY FOR ANY DISPUTE INVOLVING THIS AGREEMENT, THE EXECUTIVE’S EMPLOYMENT, TERMINATION, COMPENSATION, OR
BENEFITS AND HEREBY EXPRESSLY WAIVE ANY RIGHT THEY HAVE, OR MAY HAVE, TO A COURT TRIAL OR A JURY TRIAL OF ANY SUCH DISPUTE.

 

In making an award, the arbitrator
shall have no power to add to, delete from or modify this Agreement, or to enforce purported unwritten or prior agreements, or to construe
implied terms or covenants into the Agreement. In reaching a decision, the arbitrator shall adhere to the relevant law and applicable
precedent, and shall have no power to vary therefrom. In construing this Agreement, its language shall be given a fair and reasonable
construction in accordance with the intention of the parties and without regard to which party drafted it. At the time of issuing a decision,
the arbitrator shall (in the decision or separately) make specific findings of fact, and shall set forth such facts as support the decision,
as well as conclusions of law, and the reasons and bases for the opinion. In the event the arbitrator exceeds the powers or jurisdiction
here conferred, or fails to issue a decision in conformance herewith, it is specifically agreed that the aggrieved party may petition
a court of competent jurisdiction to correct or vacate such award, and that the arbitrator’s act of exceeding his or her powers
shall be grounds for granting such relief. If any one or more provisions of this arbitration clause shall for any reason be held invalid
or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make
it or its application valid and enforceable.

 

		7.	Jurisdiction and Venue:

 

To the extent
that either party is permitted to file any action in court that involves any aspect of this Agreement, or arises out of, or is related
to or connected with Executive’s employment, compensation or benefits, or the termination thereof, the parties agree that such action
must be brought in either federal court in Minnesota, or in state courts of the Fourth Judicial District (Hennepin County), and the parties
irrevocably consent to jurisdiction and venue in such courts.

 

    

    Page5

    

 

		8.	Attorneys’ Fees:

 

Should any arbitration
or litigation commence between the parties concerning this Agreement or the rights and obligations of either party, whether it be an action
for damages, equitable or declaratory relief, if the party commencing legal action is the prevailing party in any arbitration or litigation,
said party shall be entitled to recovery from the other party, as an element of its costs, in addition to other relief as may be granted
by the arbitrator or court, reasonable sums as and for attorneys’ fees incurred in such arbitration or litigation.

 

		9.	Miscellaneous Provisions:

 

(a) All
payments required to be made by the Company to Executive (or his heirs, executors, administrators, or estate) shall be subject to the
withholding of such amounts, if any, relating to federal, state and local taxes and other payroll deductions as the Company may reasonably
determine it should withhold pursuant to any applicable law, regulation or order.

 

(b) The
Company’s or Executive’s refraining from exercising any right under this Agreement for a reasonable period of time when it
is permissible for the Company or Executive to exercise such right shall not constitute a waiver by either of them of any such right,
unless so provided in a writing signed by both Parties and shall not prevent the Company or Executive from exercising any such right at
any time.

 

(c) Executive
agrees to keep the financial terms of this Agreement confidential; provided, however, that Executive may disclose the financial terms
of this Agreement to his attorney, accountant, financial advisor and spouse, and to government agencies for the purpose of payment or
collection of taxes or application for unemployment compensation benefits. Executive may also disclose the financial terms of this Agreement
if required to do so by lawful subpoena, in any proceeding to enforce the terms of this Agreement, or in any mediation or arbitration
under the terms of this Agreement. Executive may also disclose the existence and terms of the covenants in paragraphs 4 and 5 of this
Agreement to any prospective or subsequent employer.

 

(d) If
any claim is asserted or any litigation is threatened or pursued against Executive by a previous employer or an affiliate of a previous
employer related to Executive’s previous employment, the Company shall either: (i) defend and indemnify Executive, and hold Executive
harmless, against and in respect of any and all such demands, judgments, costs, and expenses (including reasonable attorneys’ fees),
losses, and damages arising from such claim or litigation; or (ii) terminate Executive’s employment Without Cause as provided under
subparagraph 3(b) of this Agreement.

 

(e) Notwithstanding anything
in this Agreement to the contrary, all payments to be made upon a termination of employment under this Agreement shall only be made upon
a “separation from service” within the meaning of Section 409A of the Internal Revenue Code (the “Code”). To
the maximum extent permitted under Section 409A of the Code and its corresponding regulations, the cash severance benefits payable
under this Agreement are intended to meet the requirements of the short-term deferral exemption under Section 409A of the Code and the
“separation pay exception” under Treas. Reg. §1.409A-1(b)(9)(iii). For purposes of the application of Treas. Reg. §
1.409A-1(b)(4)(or any successor provision), each payment in a series of payments to the Executive will be deemed a separate payment.
With respect to any expense, reimbursement or in-kind benefit provided pursuant to this Agreement that constitutes a “deferral
of compensation” within the meaning of Section 409A of the Code and its implementing regulations and guidance, (i) the expenses
eligible for reimbursement or in-kind benefits provided to the Executive must be incurred during the Employment Period (or applicable
survival period), (ii) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive during any calendar
year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive in any other calendar
year, (iii) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last
day of the calendar year following the calendar year in which the applicable expense is incurred, and (iv) the right to payment or reimbursement
or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit.

 

    

    Page6

    

 

(f) All
notices and other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have
been given if delivered personally or sent by Federal Express or UPS next-day delivery, or by certified express mail, return receipt requested,
postage prepaid, to the parties to this Agreement as the following addresses or to such other address as either party may specify by notice
to the other:

 

If to the Company:

 

Chief Executive Officer 

FOXO Technologies, Inc.

220 S 6th St #1200

Minneapolis, MN 55415

 

If to the Executive:

 

Robert Potashnick

 

		10.	Prior Obligations and Information of Others:

 

(a) Prior
Obligations: Executive represents and warrants that he is free to enter into this Agreement and accept employment with the Company upon
the terms and conditions set forth in this Agreement, and that the terms and conditions in this Agreement will not cause Executive to
violate any obligation that Executive owes to any prior employer.

 

(b) Information
of Others: During Executive’s employment with the Company, Executive will not disclose to the Company, or use, or induce the Company
to use, any confidential or proprietary information of any prior employer in violation of any obligation that Executive owes to such prior
employer.

 

		11.	Effective Date: Each of the Parties is signing this Agreement with
the intent to be legally bound by it. This Agreement shall become effective upon the date on which Executive executes a copy of this Agreement
that has already been signed by the Chief Executive Officer on behalf of the Company, and delivers the executed Agreement to the Company.

 

		12.	Construction: Except as may be expressly provided herein, the validity,
interpretation, construction, performance and enforceability of this Agreement shall be governed in all respects by the laws of the State
of Minnesota, without application of its conflict of laws principles.

 

		13.	Successors and Assigns: This Agreement shall be binding upon the parties’
heirs, successors and assigns. The obligations and covenants of the Executive under this Agreement, being personal, may not be delegated
or assigned.

 

		14.	Severability: If any provision of this Agreement is held invalid
or unenforceable by any court of competent jurisdiction or by an arbitrator, the other provisions of this Agreement will remain in full
force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect
to the extent not held invalid or unenforceable.

 

    

    Page7

    

 

		15.	Entire Agreement: This Agreement is the entire agreement between the
parties concerning the terms of Executive’s employment and supersedes any and all prior agreements or understandings between them
concerning its subject matter, oral or written. This Agreement may be not changed or terminated orally, and no change, termination or
attempted waiver of any of the provisions hereof shall be binding unless in writing signed by Executive and the President.

 

		16.	No Waiver: The waiver by either party of any term, condition or provision
of this Agreement shall not be construed as a waiver of any other or subsequent term, condition or provision of this Agreement.

 

		17.	Voluntary Agreement: Executive and the Company represent and agree
that each has reviewed all aspects of this Agreement, each has carefully read and fully understands all provisions of this Agreement,
each has had opportunity to review any and all aspects of this Agreement with the legal, tax, or other advisors of such party’s
choice, and each is voluntarily entering into this Agreement.

 

		18.	Photocopies: Photocopies of this signed Agreement are as binding and
as legally enforceable as a signed original.

 

	 	For FOXO Technologies, Inc.
	 	 	 
	 	By:	/s/ Jon Saves
	 	 	Jon Sabes
	 	 	 
	 	 	12/29/2020
	 	 	Date

 

    

    Page8

    

 

	 	By:	/s/ Robby Potashnick
	 	 	Robby Potashnick
	 	 	 
	 	 	12/29/2020
	 	 	DateExhibit 10.14

 

AMENDED & RESTATED EMPLOYMENT
AGREEMENT

 

THIS AMENDED AND RESTATED EMPLOYMENT
AGREEMENT (this “Agreement”) is by and between GWG Holdings, Inc., a Delaware corporation (together with its
subsidiaries including Life Epigenetics Inc. (“LEGX”), the “Company”), and Brian Chen
(“Employee”), and entered into effective as of August 20, 2017 (the “Effective Date”) and replaces all
previous agreements, whether written or oral between the Company and the Employee.

 

INTRODUCTION

 

The
Company, through its wholly owned subsidiary, LEGX, is a life science technology company committed to finding and applying
epigenetic and related science and technology to transforming the life insurance and health and wellness industries (the
“Business”). Employee desires to serve the Company in such role and provide the Company with such covenants.
Accordingly, the parties wish to enter into this Agreement setting forth their respective rights and obligations.

 

AMENDED AND RESTATED AGREEMENT

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants set forth herein, and for other
good and new valuable consideration set forth in Section 3.1 below in the form of the Phantom Equity Rights, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

1.  Certain
Definitions.

 

1.1  “Code”
means the Internal Revenue Code of 1986, as amended, including and succeeding provisions of law and any regulations promulgated by the
United States Treasury Department thereunder.

 

1.2  “Employment
Period” means the employment term as defined under Section 7 this Agreement.

 

1.3
“Good Cause” means any one or more of the following: (a) the commission by Employee of an act relating to
Employee’s duties constituting a misdemeanor or a felony under the laws of the United States or any state or political
subdivision thereof or any other jurisdiction; (b) the commission by Employee of an act constituting a breach of fiduciary duty or
willful misconduct; (c) conduct by Employee that is detrimental to the Business or the reputation, character or standing of the
Company or any of its affiliates; (d) the commission by Employee of an act of fraud, dishonesty or misrepresentation related to
Employee’s duties that is detrimental to the Business or the reputation, character or standing of the Company or any of its
affiliates; (e) Employee’s engagement in self-dealing, or his involvement in a transaction involving a conflict of interest
without the prior written approval of the Board; (f) the failure of the Employee to perform the functions required by the Company at
a level satisfactory to the Employee’s direct supervisor; or (g) a breach by Employee of his obligations under this
Agreement.

 

     

     

    

 

1.4  “Good
Reason” means a resignation by Employee of his employment hereunder upon the occurrence of any of the following events taking place
without Employee’s prior written approval: (a) a material reduction, either from one year to the next, or within the current year,
in the Employee’s base salary or bonus; (b) a failure by the Company to provide adequate resources to develop Technology; (c) decision
by the Company to stop developing, contracting, or funding the development of Technology; or (d) a material breach by the Company of any
of its obligations contained in this Agreement that to the extent an act or omission giving rise to cause to the material breach is not
reasonably susceptible to cure, the Company shall be given a reasonable opportunity, not to exceed thirty (30) days, after written notice
by the Employee to the Company to cure such act or omission.

 

1.5  “Technology”
means the commercialization of epigenetic methylation technology in general.

 

 2. Employment and Duties.

 

2.1  The
Company agrees to continue to employ Employee for the Employment Period, and Employee agrees to remain in the employ of the Company for
the Employment Period. The term of this Agreement shall continue as described in, and until such time as the employment of Employee is
terminated pursuant to, Section 7 below.

 

2.2  The
Company is employing Employee hereunder as for the position of Chief Science Officer described in Exhibit A and is expected to perform
and fulfill job functions commonly associated with such positions on behalf of the Company. In this regard, Employee agrees to perform
such duties and responsibilities, in good faith and for the exclusive benefit of the Company, as are prescribed for him under this Agreement,
the Company’s corporate bylaws, and as otherwise directed by the Employee’s direct supervisory report, or their superior officer
within the Company. Without limiting the foregoing, Employee’s duties shall in any event include overseeing the development of Company
Technology as set forth in Exhibit A.

 

2.3  Employee
shall reasonably allocate his business time, attention, energies and skills shall to the Company and the Business; provided, however,
that Employee shall be entitled to participate in social, civic or professional associations or engage in passive outside investment activities
which may require a limited portion of time and effort to manage (consistent at all times with Company’s policies and procedures),
so long as such activities do not interfere with the performance of Employee’s duties nor compete, in any way, with the products
or services offered by or through Company.

 

3.  Compensation.
For services rendered by Employee during the Employment Period, the Company shall provide the Employee with the elements of compensation
as set forth in Exhibit A.

 

3.1
Simultaneous to the execution of this Agreement, shall be execution and delivery of a Phantom Equity Rights Agreement in the form
attached hereto as Exhibit B (such incentive, the “Phantom Equity”), the purpose and intent of which is to enable
Employee to participate in the economic growth of value of the Business during the Initial Term of this Agreement.

 

    B-2

     

    

 

3.2  Employee
shall be entitled during the Employment Period to participate in all current human resource benefit programs made available from time
to time to other management-level employees of the Company and its subsidiaries.

 

3.3  Employee
and Employee’s qualified family members, as the case may be, shall be eligible to participate in, and shall receive all benefits
under, the human resource benefit programs made available from time to time to other management-level employees of the Company and its
subsidiaries.

 

3.4  Employee
shall be entitled to receive reimbursement for all reasonable expenses incurred by Employee in connection with the Business of the Company
in accordance with the applicable policies, practices and procedures of the Company and its affiliates.

 

 4. Inventions.

 

4.1  Employee
agrees that any Invention, as defined below, shall be the sole and exclusive property of the Company, and further agrees to: (a) promptly
and fully inform the Company in writing of any such Inventions; (b) assign to the Company all of Employee’s rights in and to such
Inventions, and to applications for patents and copyright registrations and to patents and copyright registrations granted upon such Inventions
in the United States or in any foreign country; and (c) promptly acknowledge and deliver to the Company, without charge to the Company
but at the Company’s expense, such written instruments and perform such other acts as may be necessary, in the reasonable opinion
of the Company, to obtain and maintain patents and copyright registrations and to vest the entire rights, interest in and title thereto
in the Company.

 

4.2  Employee
and the Company understand that the provisions of this Agreement requiring assignment of Inventions to the Company will not apply to any
particular Invention that meets each and all of the following criteria: (a) Employee develops entirely on his own time, completely outside
of Employee’s normal working hours; (b) Employee develops related to the work detailed in Exhibit A without using Company equipment,
supplies, facilities or trade secret or Confidential Information, as defined below; (c) does not result from any work performed by Employee
for the Company; and (d) does not, either at the time of conception or at the time of reduction to practice, directly relate to the Company’s
Business, as then conducted or planned to be conducted at the time of conception or at the time of reduction to practice. Any such Invention
meeting all of the criteria set forth in clauses (a) through (d) above will be owned entirely by Employee, even if developed by Employee
during the Employment Period or otherwise during the time period of his employment or association with the Company. Finally, Employee
agrees and covenants that he will not individually file any patent applications relating to Inventions without first obtaining an express
release from a duly authorized Company representative, except for those related to the work detailed in Exhibit A according to the limitations
specified in (b) above.

 

4.3 For purposes of this
Agreement, the term “Inventions” means all discoveries, improvements, inventions, ideas and works of authorship, whether
patentable or copyrightable, conceived or made by Employee either solely or jointly with others, and relating to any consultation,
work or services performed by Employee with, for on behalf of or in conjunction with the Company or based on or derived from
Confidential Information.

 

 5. Confidential Information.

 

5.1  Employee
will hold all Confidential Information, as defined below, in the strictest confidence and never use, disclose or publish any Confidential
Information without the prior express written permission obtained from a representative duly authorized by the CEO. Employee agrees to
maintain control over any Confidential Information obtained prior to or during the term of this Agreement, and restrict access thereto
to the Company’s employees, agents or other associated parties who have a need to use such Confidential Information for its intended
purpose.

 

    B-3

     

    

 

5.2  Promptly
upon the Company’s written request (but in any event within ten days), all records and any compositions, articles, devices and other
items which disclose or embody Confidential Information in Employee’s possession, including all copies or specimens thereof, regardless
of whether prepared or made by Employee or by others, will be destroyed by Employee and Employee will certify in writing to the Company
that he has destroyed all Confidential Information and embodiments thereof as required under this Agreement.

 

5.3  For
purposes of this Agreement, the term “Confidential Information” shall mean all information developed by Employee as a result
of his work with, for, on behalf of, or in conjunction with, the Company and any information relating to the Company’s processes
and services, including information relating to research, know-how, formulae, product or service ideas, inventions, trade secrets, patents,
patent applications, systems, products, programs and techniques and any secret, proprietary or confidential information, knowledge or
data of the Company, except such information that was developed by Employee prior to his employment by the Company. All information disclosed
to Employee or to which Employee obtains access, whether originated by Employee or by others, and which is treated by the Company as “Confidential
Information” or which Employee has a reasonable basis to believe is “Confidential Information,” will be presumed to
be “Confidential Information” for purposes of this Agreement. Notwithstanding the foregoing, the term “Confidential
Information” will not apply to information which (i) Employee can establish by documentation was known to Employee prior to its
receipt by Employee from the Company, (ii) is lawfully disclosed to Employee by a third party not deriving such information from the Company,
(iii) is presently in the public domain or becomes a part of the public domain through no fault of Employee, or (iv) is required to be
disclosed pursuant to applicable law, rule, regulation, or court or administrative order; provided, however, that Employee shall take
reasonable steps to obtain confidential treatment for such items and shall promptly advise the Company of Employee’s notice of any
such requirement in order to permit the Company to obtain such confidential treatment on its own behalf.

 

6. No Solicitation
of Customers or Employees; Restrictive Covenant. Employee acknowledges that the Company has invested and will continue to invest
substantial time, effort and expense in acquiring and compiling its confidential, proprietary and trade secret information and in
assembling its present staff of personnel. In order to protect the business value of the Company’s confidential, proprietary
and trade secret information, during Employee’s employment with the Company and for twelve (12) months immediately following
the termination of that employment with the Company, Employee agrees: (a) that all information regarding actual or prospective (i)
partners of the Company (including but not limited to financiers, reinsurance companies, insurance companies, digital start-ups and
insurance testing companies) relating to Technology or (ii) customers of the Company relating to Technology, of which Employee
learns during his employment with the Company, constitutes “Confidential Information” of the Company; (b) not to,
directly or indirectly, induce or solicit any employees of the Company or its affiliates to leave their employment with the Company
or any of its affiliates without the unanimous prior written consent of the Chief Executive Officer of the Company. Each of the
restrictive covenants set forth above are separate and severable covenants under this Section 6.

 

7.  Termination.
The initial term of this Agreement will begin on the date first written above and shall continue until the five-year anniversary of such
date (“Initial Term”) and shall automatically renew for one year terms thereafter (“Renewal Terms”) (collectively
the Initial Term and Renewal Terms referred to herein as “Employment Period”). Nevertheless, Employee’s employment under
this Agreement may be earlier terminated in any of the followings ways: (a) by the Company or Employee by providing written notice no
less than thirty (30) days prior to the completion of the Initial Term or a Renewal Term; (b) immediately and automatically upon Employee’s
death; (c) by the Company, upon not less than 14 days prior written notice to Employee, as a result of Employee’s incapacity due
to physical or mental illness or injury resulting in Employee’s absence from his full-time duties hereunder for four consecutive
weeks, subject to Employee’s right to cure during the 14-day period; (d) by the Company immediately for Good Cause; (e) by the Company
upon not less than 14 days prior written notice to Employee for any reason or no reason; (f) by Employee immediately for Good Reason;
or (g) by Employee upon not less than 90 days prior written notice to the Company for any reason or no reason.

 

8.  Effects
of Termination. Following any termination of Employee’s employment under this Agreement, all compensation and benefits provided
to Employee under this Agreement shall cease to accrue as of the date of such termination, except as set forth in the paragraphs below.

 

    B-4

     

    

 

8.1  In
the case of a termination arising under Section 7(b) from Employee’s death or under Section 7(c) from Employee’s incapacity,
the Company shall, for a period of one month following such death, pay to the estate of Employee an amount equal to Employee’s monthly
payment of the then current Base Salary, including any earned but unpaid annual compensation and continue the welfare benefit programs
contemplated under Section 3.5 above, including paying all premiums for coverage for Employee’s dependent family members under all
health, hospitalization, disability, dental, life and other insurance plans that the Company maintained at the time of Employee’s
death.

 

8.2 In the case of a
termination arising under Section 7(e) from the Company’s termination without Good Cause, or under Section 7(f) from
Employee’s termination with Good Reason, then, subject in all cases to Employee’s execution and delivery to the Company
of a general release and waiver of claims (including claims under contracts, claims under torts, claims as an employee, of the
Company or any of its affiliates, if applicable; it being understood that there will not be a release of any rights under the
Phantom Equity Agreement or any subsequent equity agreements, as specified in those agreements) in a customary and negotiated form
reasonably acceptable to the parties.

 

8.3  In
the case of a termination arising under Section 7(d) from the Company’s termination with Good Cause or under Section 7(g) from the
resignation of the Employee, then (a) no severance or continued benefits shall be due to Employee.

 

9.  Return
of Company Property. All correspondence, reports, records, charts, advertising materials, designs, patents, business plans, financial
statements, manuals, memoranda, lists, and other personal property of the Company or its affiliates and in the possession of Employee
shall be and remain the property of the Company and its affiliates, as applicable. Any such documentation, information or property that
is in the possession of Employee shall be delivered promptly to the Company upon termination of Employee’s employment.

 

 10. Non-Competition.

 

10.1  In
consideration of the various benefits provided by the Company to Employee under this Agreement, Employee agrees to be bound by the restrictive
covenant set forth in this Section. Employee recognizes and acknowledges the competitive and proprietary nature of the Business. Accordingly,
Employee agrees that, during the applicable Restricted Period, as defined below, Employee shall not, without the prior written consent
of the Company (which the Company shall not unreasonably withhold or condition), for himself or on behalf of any other person or entity,
directly or indirectly, either as principal, agent, stockholder, lender, consultant, officer, director, employee, agent, representative
or in any other capacity, own, manage, operate or control, or be concerned, connected or employed by, or otherwise associate in any manner
with, or engage in or have any financial interest in, any enterprise engaging in the Restricted Business, as defined below, anywhere in
the Restricted Territory, as defined below.

 

10.2  Nothing
contained in this Agreement shall preclude Employee from purchasing or owning common stock or equity in any company engaging in the Restricted
Business if such stock is publicly traded and Employee’s holdings therein do not exceed one percent of the total number of issued
and outstanding shares of capital stock of such company.

 

10.3  For
purposes of this Agreement: (a) “Restricted Period” means the period commencing on the date of this Agreement and ending on
the one year anniversary of the expiration or termination of this Agreement if Employee’s employment is terminated with Good Cause
or if he resigns without Good Reason. (b) “Restricted Business” means the Technology of the Company (including any portion
of the Technology conducted through affiliates or subsidiaries of the Company) as conducted as of the date of expiration or termination
of this Agreement (and as previously conducted within the two years prior to the date of such expiration or termination ), including any
substantially similar business that is competitive with the Technology; and (c) “Restricted Territory” means anywhere in the
United States where the Company or any of its affiliates, directly or indirectly, conducts the Technology as of the date of expiration
or termination of this Agreement.

 

    B-5

     

    

 

10.4 If any part of this
Section 10 (or any of the restrictive covenants set forth in Section 6 above) should be determined by an arbitrator or court of
competent jurisdiction to be unreasonable in duration, geographic area, or scope, then this Section 10 (and Section 6 above, if
applicable) is intended to and shall extend only for such period of time, in such geographic area and with respect to such activity
as is determined by such arbitrator or court to be reasonable.

 

11.  Indemnification.
If Employee is made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative (other than (i) an action directly by the Company against Employee, and other than (ii) such a threatened, pending or
completed suit or proceeding brought against Employee and/or the Company by a third- party and which obligates Employee to provide the
Company indemnity under Section 13 below), by reason of or in connection with the fact that Employee is or was performing services for
the Company under this Agreement, then the Company shall indemnify Employee against all expenses (including reasonable attorneys’
fees), judgments, fines and amounts paid in settlement, as actually and reasonably incurred by Employee in connection therewith to the
maximum extent permitted by applicable law. In the event that both Employee and the Company are made a party to the same third-party action,
complaint, suit or proceeding, the Company agrees to engage competent legal representation, and Employee agrees to use the same representation,
provided that if counsel selected by the Company shall have a conflict of interest preventing such counsel from representing Employee,
Employee may engage separate counsel of his choosing and the Company shall pay all reasonable attorneys’ fees of such separate counsel.
To the maximum extent permitted by law, Employee shall not be entitled to indemnification or expense advances under this Agreement in
any case where he has exhibited gross negligence or willful misconduct, or performed criminal or fraudulent acts, or engaged in violations
of federal securities laws; and the Company may withhold expense advances if it reasonably determines that Employee is not entitled to
indemnification hereunder because of gross negligence, willful misconduct, the performance of criminal or fraudulent acts or the violation
of federal securities laws.

 

12. Parachute
Payments. If any payment or benefit (any “Payment”) Employee would receive from the Company pursuant to or in
connection with a “Change in Control” as defined in the Treasury Regulations promulgated under Code §280G would (i)
constitute a “parachute payment” within the meaning of Code §280G, and (ii) but for this sentence, be subject to
the excise tax imposed by Code §4999 (the “Excise Tax”), then such Payment shall be adjusted to equal to the
Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment (prior to adjustment) that
would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion of the Payment (prior to
adjustment), which, after taking into account all applicable federal, state and local employment taxes, income taxes and the Excise
Tax (all computed at the highest applicable marginal rate), results in Employee’s receipt, on an after-tax basis, of the
greater amount of the Payment (than that calculated under clause (x) above) notwithstanding that all or some portion of the Payment
may be subject to the Excise Tax. If a reduction in payments or benefits constituting “parachute payments” is necessary
so that the Payment equals the Reduced Amount, reduction shall occur in the following order unless Employee elects, in writing, a
different order (provided, however, that such election shall be subject to the Company’s approval if made on or after the
effective date of the event that triggers the Payment): reduction of cash payments; cancellation of accelerated vesting of stock
options, if any; and reduction of employee benefits. In the event that acceleration of vesting of the stock options is to be
reduced, such acceleration of vesting shall be cancelled in the reverse order of the date of grant of Employee’s stock options
(i.e., the earliest granted stock option will be cancelled last) unless Employee elects, in writing, a different order for
cancellation.

 

13.  No
Conflicting Agreements. Employee represents and warrants to the Company that the execution of this Agreement by Employee and
Employee’s employment by the Company, and the performance of Employee’s duties hereunder, will not violate or breach any agreement
with any former or existing employer, client, or any other person, firm or entity, to which agreement Employee is a party or by which
agreement Employee is bound. Employee also represents and warrants that he is not affiliated in any manner (whether as a stockholder,
member, partner, manager, director, officer, employee or otherwise) with any person or entity that has any business relationship with
the Company. Furthermore, Employee agrees to indemnify the Company from and against any and all losses, liabilities, damages and claims,
including but not limited to reasonable attorneys’ fees and costs and expenses of investigation, arising from any third-party claim
made against the Company and based upon or arising out of any non-competition or confidentiality agreement between or among Employee and
any such third party.

 

    B-6

     

    

 

14.  Assignment;
Binding Effect. Employee understands that the Company is employing him on the basis of his personal qualifications, experience and
skills. Therefore, Employee agrees that he cannot delegate any portion of his obligations of performance under this Agreement. However,
Employee can employ, as appropriate, a staff to assist him in carrying out his responsibilities; provided that such assistance may be
limited by budgetary constraints and the failure of such staff cannot serve as a reason for inadequate job performance by the Employee.
Employee may also not assign any of his rights under this Agreement without the prior written consent of the Company, which consent may
be conditioned or withheld in the sole and complete discretion of the Company. Subject to the preceding two sentences, this Agreement
shall be binding upon, inure to the benefit of and be enforceable by the parties and their respective heirs, legal representatives, and
permitted successors and assigns.

 

15.  Complete
Agreement. This Agreement is not a promise of future employment. Except as specifically provided herein, Employee has received no
oral representations, and has no other understandings or agreements with the Company (oral or written) or any of its officers, directors
or representatives covering the same subject matter as this Agreement. This written Agreement, together with its exhibits and schedules,
is the final, complete and exclusive statement and expression of the agreement between the Company and Employee pertaining to Employee’s
employment. This written Agreement may not be later modified except in a writing signed by a duly authorized officer of the Company and
Employee, and no term of this Agreement may be waived except by a writing signed by the party waiving the benefit of such term. This Agreement
hereby supersedes any other employment agreements or understandings, written or oral, between the Company and Employee.

 

16.  Notices.
Whenever any notice is required hereunder, it shall be given in writing addressed as follows:

 

If to the Company:

 

With a copy to:

 

If to Employee:

 

Notice shall be deemed to be delivered four days after
it is mailed by registered or certified mail, postage prepaid, return receipt requested or one day after it is sent by a reputable overnight
courier service. Either party may change the address for notice by notifying the other party of such change in accordance with this Section.

 

17.  Severability;
Blue Pencil Doctrine. In the event that any one or more of the provisions of this Agreement or any application thereof, shall
be found to be invalid, illegal or otherwise unenforceable, the validity, legality and enforceability of the remaining provisions and
any application thereof, shall not in any way be affected or impaired thereby. To the extent any provision of this Agreement is determined
by an arbitrator or court of competent jurisdiction to be unenforceable, the arbitrator or court of competent jurisdiction shall reform
any such provision to make it enforceable. The provisions of this Agreement shall, where possible, be interpreted so as to sustain their
legality and enforceability.

 

 18. Dispute Resolution.

 

18.1  To
the greatest extent possible, the parties will endeavor to resolve any disputes relating to the Agreement through amicable negotiations.
Failing an amicable settlement, any controversy, claim or dispute arising under or relating to this Agreement, including the existence,
validity, interpretation, performance, termination or breach of this Agreement, will finally be settled by binding arbitration before
a three person arbitrator (the “Arbitration Tribunal”) which will be jointly appointed by the parties. The Arbitration Tribunal
shall self-administer the arbitration proceedings utilizing the Commercial Rules of the American Arbitration Association (“AAA”);
provided, however, the AAA shall not be involved in administration of the arbitration. The Arbitration Tribunal must consist of one retired
judge of a state or federal court of the United States or a licensed lawyer with at least 15 years of corporate or commercial law experience.

 

    B-7

     

    

 

18.2 The arbitration will
be held in Minneapolis, Minnesota. Each party will have discovery rights as provided by the Federal Rules of Civil Procedure within
the limits imposed by the arbitrators. It is the intent of the parties that any arbitration will be concluded as quickly as
reasonably practicable. Once commenced, the hearing on the disputed matters will be held four days a week until concluded, with each
hearing date to begin at 9:00 a.m. and to conclude at 5:00 p.m. The arbitrators will use all reasonable efforts to issue the final
written report containing award or awards within a period of five business days after closure of the proceedings. Failure of the
arbitrators to meet the time limits of this Section will not be a basis for challenging the award. The Arbitration Tribunal will not
have the authority to award punitive damages to either party. Each party will bear its own expenses, but the parties will share
equally the expenses of the Arbitration Tribunal. The Arbitration Tribunal shall award attorneys’ fees and other related costs
payable by the losing party to the successful party as it deems equitable. This Agreement will be enforceable, and any arbitration
award will be final and non-appealable, and judgment thereon may be entered in any court of competent jurisdiction. Notwithstanding
the foregoing, claims for injunctive relief for breaches of Sections 4, 5, 6, 9 and 10, and claims to enforce arbitration awards,
may be brought in a state or federal court in the state court in Minnesota.

 

19.  Equitable
Relief. Employee acknowledges and agrees that it would be difficult to fully compensate the Company for damages resulting from the
breach or threatened breach of the covenants contained in Sections 4, 5, 6, 9 and 10 of this Agreement, and that any such breach may cause
the Company irreparable harm. Accordingly, the Company will be entitled to seek injunctive relief, including but not limited to temporary
restraining orders, preliminary injunctions and permanent injunctions, to enforce the terms thereof, without the need to demonstrate irreparable
harm or, to the extent permitted by applicable law, the need to post any bond. This right to injunctive relief will not, however, diminish
any of the Company’s other legal rights under this Agreement or at law.

 

20.  Governing
Law; Jurisdiction and Venue. This Agreement shall in all respects be construed according to the laws of the State of Minnesota, notwithstanding
the conflicts-of-law provisions of such state. Subject to the provisions of Section 18 above, any claims for injunctive relief arising
under this Agreement, and any claims to enforce an earlier issued arbitration award, shall be exclusively decided by a state or federal
court in the State of Minnesota. Employee hereby irrevocably waives his right, if any, to have any disputes between him and the Company
arising out of or related to this Agreement decided in any jurisdiction or venue other than a state or federal court in the State of Minnesota.
Furthermore, Employee hereby irrevocably (a) waives any objection that he might have now or hereafter to the foregoing jurisdiction and
venue of any such proceeding, (b) submits to the exclusive jurisdiction of any such court set forth above in any such proceeding, and
(c) waives any claim or defense of inconvenient forum.

 

21.  Further
Assurances. Each party shall, without further consideration, execute such additional documents as may be reasonably required in order
to carry out the purposes and intents of this Agreement.

 

22.  Interpretation.
Employee has had a meaningful opportunity to work with legal counsel of his choosing and has either availed himself of such opportunity
to his satisfaction or has independently determined not to seek such counsel. Furthermore, Employee has a meaningful opportunity to review
and negotiate the terms and conditions of this Agreement. Since both parties have participated in the negotiation, drafting and finalization
of their business relationship and documented such relationship in this Agreement, this Agreement will not be interpreted as though it
has been drafted solely by the Company.

 

23. Waivers. No
term or condition of this Agreement will be deemed to have been waived nor shall there be any estoppel to enforce any provision
hereof, except by a written instrument executed by the party charged with waiver or estoppel. A party’s delay, waiver or
failure to enforce any of the terms of this Agreement or any similar agreement in one instance shall not constitute a waiver of its
rights hereunder with respect to other violations of this or any other agreement.

 

24.  Counterparts
and Delivery. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together
shall constitute but one and the same instrument. Counterpart signatures delivered by facsimile or other means of electronic transmission
shall be valid and binding to the same as the delivery of original ink signatures.

 

    B-8

     

    

 

IN WITNESS WHEREOF, the parties have
executed this Employment Agreement as of the date first above written.

 

	COMPANY:	 	EMPLOYEE:
	 	 	 	 
	GWG HOLDINGS, INC.	 	Brian Chen
	 	 	 	 
	By:	/s/ Jon Sabes	 	/s/ Brian Chen
	Name: 	Jon Sabes 	 	Name: 	 Brian Chen
	Title:	CEO	 	 

 

Signature Page]

 

    B-9

     

    

 

Exhibit A

 

Employment Activities

 

Title:
Chief Science Officer (“CSO”)

 

The Chief Science Officer will
be responsible for leading the development of commercializing epigenetic predictive technology.

 

The scientific efforts will involve
a variety of challenging endeavors as Life Epigenetics seeks to commercialize epigenetic technology initially for the life insurance industry,
but even more broadly for the health and wellness industries.

 

Job Description:

 

The Chief Science Officer will
oversee the scientific development of epigenetic biomarkers that are predictive as to individual health and wellness. In addition, the
CSO will work to understand the integration of individual health and wellness measurements into insurance underwriting.

 

The area of responsibility for
this role encompasses both scientific and analytic expertise. The CSO is required to have and maintain expertise in the biology and epidemiology
of human health, biomarkers, functional testing, and mortality risk factors. In addition, the CSO must have the experience in developing
analytical pipelines for “big data” and stay on the cutting edge of human health research in order to identify new measures
of life expectancy.

 

Responsibilities/Goals:

 

		1.	Design epigenetic signatures that mirror established measures
of health and wellness.

 

		2.	Create a panel of epigenetic signatures capable of replacing
the need for paramedical testing of blood/urine used in life insurance underwriting.

 

		3.	Work to create an intellectual property strategy that protects
the epigenetic signatures developed, as well as maintain the freedom to operate around any outstanding intellectual property.

 

		4.	Actively participate (and manage where appropriate) on organizational
decision making on the operational activities and corporate direction in support of strategic goals.

 

Compensation:

 

Base Salary: $175,000

 

Incentive Compensation:

 

		●	Cash compensation, under development and to be proposed and
approved by the CEO, that shall be based upon the attainment of specific operational benchmarks supporting the development of epigenetic
signatures capable of replacing life insurance paramedical underwriting.

 

		●	Phantom Equity Rights (“PERs”) representing 3%
of the Valuation Amount created in the business of Life Epigenetics, Inc. (“LEGX”). PERs shall vest pro-rata over a 5 year
term, beginning on the original start date of February 6, 2017.

 

	Benefits:	Standard Benefits Health, dental, and vision insurance. 401K.

 

	Vacation:	Standard Benefits

 

	Others:	Tele-work and travel and registration for business meetings, conferences, workshops, and trainings related
to health biomarkers, analytics, and aging, as required.

 

    B-10

     

    

 

Exhibit B

 

Form of Phantom Equity Rights Agreement

 

 

B-11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]